Ido Weinberg, MD

Medical Director
Massachusetts General Hospital
Boston, Massachusetts, United States

Dr. Weinberg a vascular physician, researcher and educator. He is Associate Professor of Medicine at Harvard Medical School. He is on staff at the Massachusetts General Hospital Division of Cardiology, Section of Vascular Medicine. He is Medical Director of VasCore, a leading vascular imaging core lab and co-Medical Director of the MGH Anticoagulation Management Service. Dr. Weinebrg is an Executive Board member (President-Elect) of the Society for Vascular Medicine, on the editorial board of the Vascular Medicine Journal. He is founder of Angioloigst.com, a Vascular Medicine evidence based medicine go-to resource frequented by thousands of visitors each month.

Presentation(s):

• Awareness, Treatment and Control of CV Risk-Factors - Racial Disparities Compared with Outcome

  Sunday, February 26, 2023
  8:38 PM – 8:46 PM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)

• Panel Discussion How to Close the Gap of Disparity in Clinical Trials and Beyond

  Sunday, February 26, 2023
  8:54 PM – 9:05 PM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)

• Risk Factors and Outcomes of Elevated ABI The Medical Approach to Patients with Claudication and Critical Limb Ischemia

  Monday, February 27, 2023
  8:00 AM – 8:10 AM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)

• Panel Discussion: PAD: Diagnosis, Treatment and Definitive Therapy Options

  Monday, February 27, 2023
  9:10 AM – 9:40 AM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)

• Endovascular Intervention for DVT: Who and When?

  Monday, February 27, 2023
  2:18 PM – 2:26 PM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)

• Panel Discussion: The Evolving Endovascular Options and CTO Recanalization

  Monday, February 27, 2023
  3:14 PM – 3:30 PM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)

• THE ON-GOING DISCOURSE IN ENDO THERAPY AND THE BEST-CLI CONTROVERSY

  Monday, February 27, 2023
  4:42 PM – 5:25 PM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)

• Panel Discussion: All Things CLI

  Monday, February 27, 2023
  5:06 PM – 5:25 PM ET

  Disclosure(s): Magneto: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant (Ongoing)